Smith & Nephew

SNN · LONDON

$30.83−$0.05 (−0.16%)TodayMarket closed ·
Prev close $30.88

About SNN

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. The company is headquartered in Watford, Hertfordshire and currently employs 16,988 full-time employees. The firm is focused on the repair, regeneration, and replacement of soft and hard tissue. The firm's segments include Orthopaedics, which includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilize severe fractures and correct bone deformities; Sports Medicine & ENT businesses offer advanced products and instruments used to repair or remove soft tissue, and Advanced Wound Management provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds. The firm also owns Integrity Orthopaedics, which is an early stage commercial developer of Tendon Seam, an innovative and disruptive biomechanical RCR system.

Employees
16,988
Headquarters
Watford, Hertfordshire
Listed
Aug 13, 1951
Sector
Health Care
Industry
Health Care Equipment & Supplies

Leadership

Smith & Nephew executives
NameTitleSince
Rupert Soames——
Deepak Nath—2022
John Rogers—2023
Paul Connolly——
Craig Gaffin——
Rohit Kashyap——
Vasant Padmanabhan——
Scott Schaffner——
Elga Lohler——
Alison Parkes——
Helen Barraclough——
Phil Cowdy——
Ajay Dhankhar——
Mizanu Kebede——
Jo Hallas——
David King——
Garheng Kong——
Simon Lowth——
John Ma——
Jeremy Maiden——
Katarzyna Mazurhofsaess——
Marc Owen——
Angie Risley——
Sybella Stanley——
Andrew Swift—2025

Similar companies

Companies in the same industry as Smith & Nephew

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.